clinical trial · NCT06721494
A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine
Clear Scientific, Inc.·phase2·recruiting·n = 40
Methamphetamine IntoxicationMethamphetamine DisordersMethamphetamine AbuseMethamphetamineSterile SalineCS-1103
brief summary
The purpose of the study is to evaluate the safety, efficacy, and pharmacokinetics of four single, increasing doses of CS-1103, given by intravenous (IV) infusion in otherwise healthy, non-treatment seeking participants with methamphetamine use disorder in the presence of a clinically relevant dose of methamphetamine HCl (30 mg IV).
started
Feb 5, 2026
primary completion
Sep 4, 2026
completion
Sep 11, 2026
last updated
Jan 12, 2026
official title
A Phase 2 Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants With Methamphetamine Use Disorder Not Seeking Treatment Receiving a Single Dose of Methamphetamine
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol